Effect of levodopa on handwriting tasks of different complexity in Parkinson's disease: a kinematic study

被引:8
|
作者
Zham, Poonam [1 ]
Kumar, Dinesh [1 ]
Viswanthan, Rekha [1 ]
Wong, Kit [2 ]
Nagao, Kanae J. [2 ]
Arjunan, Sridhar Poosapadi [1 ]
Raghav, Sanjay [1 ,2 ]
Kempster, Peter [2 ]
机构
[1] RMIT Univ, Sch Engn, Melbourne, Vic 3000, Australia
[2] Monash Med Ctr, Melbourne, Vic, Australia
关键词
Parkinson's disease; Levodopa; Kinematic; Dysgraphia; BASAL GANGLIA; MICROGRAPHIA; IMPAIRMENT; TOOL;
D O I
10.1007/s00415-019-09268-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Levodopa treatment does improve Parkinson's disease (PD) dysgraphia, but previous research is not in agreement about which aspects are most responsive. This study investigated the effect of levodopa on the kinematics of writing. Twenty-four patients with PD of less than 10years duration and 25 age-matched controls were recruited. A practically defined off state method was used to assess the levodopa motor response, measured on the Unified Parkinson's Disease Rating Scale PartIII. The kinematic features for six handwriting tasks involving different levels of complexity were recorded from PD patients in off and on states and from the control group. Levodopa is effective for simple writing activities involving repetition of letters, denoting improved fine motor control. But the same benefit was not seen for copying a sentence and a written category fluency test, tasks that carry memory and cognitive loads. We also found significant differences in kinematic features between control participants and PD patients, for all tasks and in both on and off states. Serial testing of handwriting in patients known to be at risk for developing PD might prove to be an effective biomarker for cell loss in the substantia nigra and the associated dopamine deficiency. We recommend using a panel of writing tasks including sentence copying and memory dependence. Dual-task effects may make these activities more sensitive to early motor deficits, while their weaker levodopa responsiveness would cause them to be more stable indicators of motor progression once symptomatic treatment has been commenced.
引用
收藏
页码:1376 / 1382
页数:7
相关论文
共 50 条
  • [31] Levodopa: Effect on Cell Death and the Natural History of Parkinson's Disease
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2015, 30 (01) : 37 - 44
  • [32] Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: A fMRI study
    Peran, P.
    Nemmi, F.
    Meligne, D.
    Cardebat, D.
    Peppe, A.
    Rascol, O.
    Caltagirone, C.
    Demonet, J. F.
    Sabatini, U.
    BRAIN AND LANGUAGE, 2013, 125 (03) : 324 - 329
  • [33] The Effect of Levodopa on Improvements in Protective Stepping in People With Parkinson's Disease
    Peterson, Daniel S.
    Horak, Fay B.
    NEUROREHABILITATION AND NEURAL REPAIR, 2016, 30 (10) : 931 - 940
  • [34] Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase
    Ganga, Ganesvaran
    Alty, Jane E.
    Clissold, Benjamin G.
    McColl, Craig D.
    Reardon, Katrina A.
    Schiff, Mark
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2013, 28 (04) : 476 - 481
  • [35] Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease
    Gao, Lin-Lin
    Zhang, Jia-Rong
    Chan, Piu
    Wu, Tao
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (01) : 76 - 86
  • [36] Rigidity in Parkinson's Disease: The Objective Effect of Levodopa
    Falletti, Marco
    Asci, Francesco
    Zampogna, Alessandro
    Patera, Martina
    Pinola, Giulia
    Centonze, Diego
    Hallett, Mark
    Rothwell, John
    Suppa, Antonio
    MOVEMENT DISORDERS, 2025,
  • [37] Levodopa delivery systems for the treatment of Parkinson's disease: An overview
    Goole, J.
    Amighi, K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 380 (1-2) : 1 - 15
  • [38] Semantic activation in Parkinson's disease patients on and off levodopa
    Angwin, Anthony J.
    Arnott, Wendy L.
    Copland, David A.
    Haire, Miriam P. L.
    Murdoch, Bruce E.
    Silburn, Peter A.
    Chenery, Helen J.
    CORTEX, 2009, 45 (08) : 950 - 959
  • [39] Social intentions in Parkinson's disease patients: A kinematic study
    Straulino, Elisa
    Scaravilli, Tomaso
    Castiello, Umberto
    CORTEX, 2015, 70 : 179 - 188
  • [40] Unmasking levodopa resistance in Parkinson's disease
    Nonnekes, Jorik
    Timmer, Monique H. M.
    de Vries, Nienke M.
    Rascol, Olivier
    Helmich, Rick C.
    Bloem, Bastiaan R.
    MOVEMENT DISORDERS, 2016, 31 (11) : 1602 - 1609